Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. CLDI
CLDI logo

CLDI

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CLDI News

CALIDI BIOTHERAPEUTICS INC REPORTS Q4 NET LOSS OF $0.57 PER SHARE

3d agomoomoo

Calidi Biotherapeutics Accelerates CLD-401 Clinical Trial Initiation

3d agoNewsfilter

Calidi Biotherapeutics Reports FY Loss and Public Offering

3d agoseekingalpha

Calidi Partners with Avance for First-in-Human Trial of CLD-401

6d agoNASDAQ.COM

CALIDI Biotherapeutics Forms Partnership with Avance Clinical to Streamline Australian Regulatory Approval and Expedite CLD-401 Clinical Trials Launch

6d agomoomoo

Calidi Biotherapeutics Completes $6 Million Public Offering

Mar 10 2026Newsfilter

Calidi Biotherapeutics Prices Public Offering at $0.50 per Unit

Mar 09 2026NASDAQ.COM

U.S. Stocks Decline Amid Weak Retail Sales Data

Mar 06 2026Benzinga

Calidi Biotherapeutics Prices Public Offering of 10.52M Units

Mar 06 2026seekingalpha

U.S. Stocks Decline as Unemployment Rate Rises

Mar 06 2026Benzinga

Calidi Biotherapeutics Prices Public Offering of 10.5 Million Units

Mar 06 2026Newsfilter

Calidi Biotherapeutics Shares Plunge 35.04% After Public Offering Announcement

Mar 06 2026Benzinga

Calidi Biotherapeutics Announces Public Offering, Shares Plunge 31%

Mar 06 2026NASDAQ.COM

Calidi Biotherapeutics Plans Public Offering of Stock Units

Mar 05 2026Newsfilter

Calidi Biotherapeutics Announces Public Offering of Units

Mar 05 2026seekingalpha

Calidi Biotherapeutics Unveils Novel Therapy Data at AACR-IO

Feb 20 2026Yahoo Finance